Shares of Structure Therapeutics Inc. (NASDAQ:GPCR – Get Free Report) have been assigned an average rating of “Buy” from the ...

Structure Therapeutics Inc. (NASDAQ:GPCR – Get Free Report) was the recipient of a significant growth in short interest in the month of January. As of January 15th, there was short interest totalling ...

This article explores methods to enhance efficiency in the drug discovery and development pipeline, focusing on optimizing ...

The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...

Muon spin rotation (µSR) spectroscopy is a powerful technique that helps to study the behavior of materials at the atomic ...

Neurons in the brains of mice tell them to stop eating when they’ve had enough food – and since people probably have the same ...

Chromatin, the mix of DNA and protein that houses each cell's genome, is more resilient to aging than previously thought, suggests a study published in the Journal of the American Chemical Society by ...

This internal left-right asymmetry is believed to begin at the very early stage of development -- when a tiny embryo is divided into two parts during a process called gastrulation. This process ...

Novo Nordisk today announced 2024 earnings, reporting a 26% increase in annual sales to ~$40.56bn. Read why I upgrade NVO ...